We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Welcome to the latest edition of our weekly EuroBiotech Report. We start this week with Crescendo Biologics, which raised $70 million (€57 million) to progress an anti-cancer ...